BioCardia (BCDA) Gross Profit (QoQ) (2012 - 2021)
Powered by 
Analysis
BioCardia (BCDA) Gross Profit (QoQ) (2012 - 2021) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.02 Bn | 5.02 Bn | - |
| 3 | Iovance Biotherapeutics | 3.64 Bn | 3.34 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.56 Bn | 2.60 Bn | 251.50 Mn |
| 5 | uniQure | 3.01 Bn | 3.01 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.54 Bn | 2.54 Bn | - |
| 7 | Precigen | 2.36 Bn | 2.36 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.19 Bn | 1.40 Bn | 251.87 Mn |
| 9 | Vericel | 1.96 Bn | 1.80 Bn | 56.40 Mn |
| 10 | BioCardia | 13.18 Mn | 9.06 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | -90.38% |
| Sep 30, 2021 | 1,089.86% |
| Dec 31, 2020 | 35.29% |
| Sep 30, 2020 | 25.93% |
| Jun 30, 2020 | -20.59% |
| Mar 31, 2020 | -80.90% |
| Dec 31, 2019 | 4.71% |
| Sep 30, 2019 | 261.90% |
| Jun 30, 2019 | -195.45% |
| Mar 31, 2019 | 946.15% |
| Dec 31, 2018 | 48.00% |
| Sep 30, 2018 | -124.04% |
| Jun 30, 2018 | 147.62% |
| Mar 31, 2018 | 164.62% |
| Dec 31, 2017 | -282.35% |
| Sep 30, 2017 | 81.32% |
| Jun 30, 2017 | -139.47% |
| Mar 31, 2017 | -22.58% |
| Dec 31, 2016 | 60.76% |
| Sep 30, 2016 | -558.33% |